CareRx Corporation

TSX:CRRX.TO

Medical - Care Facilities

Healthcare
$3.21 +0.63%

+$0.02 today

Market cap
$203.06M
Beta
0.62
P/E (TTM)
7.4
EPS (TTM)
$0.43
Dividend yield
1.88%
52W Low $2.70High $4.00

Volume 0.01M

Average 0.04M

CRRX.TO Other Stockholders Equity

Equity items not reported separately, such as additional paid-in capital or treasury stock.

CareRx CorporationTSX: CRRX.TO

Other Stockholders Equity · Q1 FY2026 · quarter ended Mar 2026

Other stockholders equity remains negative

Q1 FY2026 other stockholders equity was CA$0, compared with CA$0 a year earlier.

Context

  • Other stockholders equity amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
  • Other stockholders equity increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$0— QoQ
Last fiscal yearDec 2025
CA$0— YoY
Year agoMar 2025
CA$0— since
Other Stockholders Equity past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Stockholders Equity history

CAD · from the balance sheet

Latest · FY2025
0 CAD
Year-over-year change
—

Other Stockholders Equity vs competitors

How CRRX.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so other stockholders equity is compared through growth and share of total assets rather than absolute size.
  • Other stockholders equity amounts to 0.0% of total assets for CRRX.TO, versus a peer median of 0.0%.
CRRX.TO Competitors
Other Stockholders Equity for CRRX.TO and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
CRRX.TOCareRx CorporationMar 2026CA$0 CAD——0.0%
PRN.TOProfound Medical Corp.Mar 2026$0 USD——0.0%
XLY.TOAuxly Cannabis Group Inc.Mar 2026CA$0 CAD-100.0%—0.0%
DR.TOMedical Facilities CorporationMar 2026$0 USD——0.0%
HLS.TOHLS Therapeutics Inc.Mar 2026$0 USD——0.0%
HBP.TOHelix BioPharma Corp.Apr 2026CA$0 CAD-100.0%—0.0%
Peer median (excluding CRRX.TO) —-100.0%—0.0%

Competitors are the stored peer set for CRRX.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents35.63M28.37M7.03M9.08M14.4M
Short-term Investments00000
Net Receivables38.11M37.26M36.09M33.15M32.9M
Inventory17.99M20.3M19.66M17.67M17.55M
Other Current Assets680K3.24M1.96M2.43M2.17M
Total Current Assets95.25M89.18M65.41M62.34M67.02M
Property, Plant & Equipment (Net)38.17M52.39M52.14M56.89M54.26M
Goodwill92.12M70.01M70.01M70.01M70.01M
Intangible Assets54.57M52.96M44.33M34.3M28.89M
Long-term Investments2.71M0000
Tax Assets000032.85M
Other Non-current Assets(187.57M)(175.36M)000
Total Non-current Assets187.57M175.36M166.48M161.2M186M
Total Assets282.82M264.54M231.89M223.54M253.02M
Account Payables33.21M30.48M29.11M31.83M33.89M
Short-term Debt733K7.41M9.92M5.33M7.87M
Tax Payables00000
Deferred Revenue13.11M0(125K)822K758K
Other Current Liabilities9.95M5.84M2.19M1.32M3.94M
Total Current Liabilities52.97M63.89M62.45M62.8M63.03M
Long-term Debt111.97M99.37M57.15M39.96M35.96M
Deferred Tax Liabilities5.46M4.01M0010.07M
Deferred Revenue (Non-current)15.16M3.23M000
Other Non-current Liabilities2.63M3.73M2.77M2M354K
Total Non-current Liabilities147.56M136.19M87.92M76.51M80.48M
Total Liabilities200.53M200.08M150.37M139.31M143.51M
Common Stock283.46M299.78M323.3M331.11M332.49M
Retained Earnings(242.93M)(277.28M)(282.69M)(287.19M)(263.58M)
Accumulated OCI9.43M7.46M7.3M583K0
Other Stockholders Equity00000
Minority Interest00000
Total Equity82.29M64.46M81.53M84.23M109.5M
Total Debt125.57M135.22M97.86M82.63M77.93M
Net Debt89.95M106.85M90.84M73.55M63.53M

CareRx Corporation

TSX:CRRX.TO

Intrinsic Alpha fair value

Locked

Current Price

$3.21

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.